AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (1.2 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

CD147 facilitates cisplatin resistance in ovarian cancer through FOXM1 degradation inhibition

Miao Wanga,1, Lin Chenb,1, Yu Wangc,1, Tian Fanb, Chunyu Zhua, Zhixian Lib, Lei Moub, Hong Yangd( ), Airong Qiana ( ), Yu Lib( )
School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China
Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China
Department of Oncology, Air Force Medical Center, PLA, Beijing 100142, China
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi 710032, China

Peer review under responsibility of Chongqing Medical University.

1 These authors contributed equally to this work.

Show Author Information

References

1

Landras A, de Moura CR, Jouenne F, Lebbe C, Menashi S, Mourah S. CD147 is a promising target of tumor progression and a prognostic biomarker. Cancers. 2019;11(11):1803.
Crossref Google Scholar
2

Bian H, Zheng JS, Nan G, et al. Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation. J Natl Cancer Inst. 2014;106(9):dju239.
Crossref Google Scholar
3

Wu B, Liu ZY, Cui J, et al. F-box protein FBXO22 mediates polyubiquitination and degradation of CD147 to reverse cisplatin resistance of tumor cells. Int J Mol Sci. 2017;18(1):212.
Crossref Google Scholar
4

Bu X, Qu X, Guo K, et al. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway. Int J Biol Sci. 2021;17(12):3013–3023.
Crossref Google Scholar
5

Chen Y, Li Y, Xue J, et al. Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation. EMBO J. 2016;35(6):668–684.
Crossref Google Scholar
Genes & Diseases
Volume 11 Issue 5,
September 2024
Article number: 101277
DOI: 10.1016/j.gendis.2024.101277
Cite this article:
Wang M, Chen L, Wang Y, et al. CD147 facilitates cisplatin resistance in ovarian cancer through FOXM1 degradation inhibition. Genes & Diseases, 2024, 11(5): 101277. https://doi.org/10.1016/j.gendis.2024.101277

153

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics
Received: 31 July 2023
Published: 24 March 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Return